Overview

Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)

Status:
Completed

Trial end date:
2018-03-01

Target enrollment:

Participant gender:

Summary

A multi-center, randomized, double-blind, active-controlled, parallel group, phase IV clinical trial to investigate the effect on blood glucose of evogliptin after oral administration in patients with type 2 diabetes

Phase:

Phase 4

Details

Lead Sponsor:

Dong-A ST Co., Ltd.

Treatments:

Linagliptin